Cymat Technologies Ltd.
CYMHF
$0.09
$0.00-1.62%
OTC PK
| 07/31/2025 | 04/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -13.09% | -80.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -13.09% | -80.20% | |||
| Cost of Revenue | -6.64% | -43.25% | |||
| Gross Profit | 0.53% | -172.39% | |||
| SG&A Expenses | -25.52% | 30.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.84% | -11.87% | |||
| Operating Income | 18.86% | -234.98% | |||
| Income Before Tax | 1.57% | -100.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.57% | -100.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.57% | -100.07% | |||
| EBIT | 18.86% | -234.98% | |||
| EBITDA | 18.97% | -401.46% | |||
| EPS Basic | 20.57% | -110.45% | |||
| Normalized Basic EPS | 25.00% | -119.05% | |||
| EPS Diluted | 20.57% | -110.45% | |||
| Normalized Diluted EPS | 25.00% | -119.05% | |||
| Average Basic Shares Outstanding | 24.06% | -4.86% | |||
| Average Diluted Shares Outstanding | 24.06% | -4.86% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||